-
Mashup Score: 0
Key Points. The primary outcome, stroke, occurred in 6 of 23 patients randomized to apixaban compared with 0 of 25 patients randomized to warfarin.This study wi
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Zia Research Group - UT Southwestern, Dallas, Texas - 3 year(s) ago
Zia Research Group at UT Southwestern, led by Dr. Ayesha Zia, focusing on pediatric hematology, including thrombosis and young women bleeding disorders.
Source: utsouthwestern.eduCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
As systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS) can cause complications during pregnancy, investigators believe it is imperative that women follow the clinical practice guidelines and receive multidisciplinary counseling before trying to conceive.
Source: Rheumatology NetworkCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 2
By Caroline Helwick Posted: 10/22/2020 10:39:00 AM Last Updated: 10/22/2020 1:41:45 PM In 2020, health-care providers from all disciplines are facing challenges never before encountered in the modern era of medicine. Advanced practitioners (APs) are playing critical roles in…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
Lifelong anticoagulation with warfarin or alternative vitamin K antagonist is the standard anticoagulant treatment for thrombotic antiphospholipid syndrome. Anticoagulant-refractory thrombotic antiphospholipid syndrome can be broadly defined as breakthrough thrombosis while on standard oral anticoagulation treatment and its management is a major challenge given the serious nature of the…
Source: The Lancet HaematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 8
Lifelong anticoagulation with warfarin or alternative vitamin K antagonist is the standard anticoagulant treatment for thrombotic antiphospholipid syndrome. Anticoagulant-refractory thrombotic antiphospholipid syndrome can be broadly defined as breakthrough thrombosis while on standard oral anticoagulation treatment and its management is a major challenge given the serious nature of the…
Source: The Lancet HaematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0GoToWebinar - 4 year(s) agoSource: register.gotowebinar.comCategories: Latest Headlines, PediatricsTweet
-
Mashup Score: 0GoToWebinar - 4 year(s) agoSource: register.gotowebinar.comCategories: Latest Headlines, PediatricsTweet
-
Mashup Score: 0GoToWebinar - 4 year(s) agoSource: register.gotowebinar.comCategories: Latest Headlines, PediatricsTweet
-
Mashup Score: 0GoToWebinar - 4 year(s) agoSource: register.gotowebinar.comCategories: Latest Headlines, PediatricsTweet
Small RCT in antiphospholipid syndrome (APS) stopped after 48th patient enrolled. 6/23 thrombosis in Apixaban arm and 0/25 in the warfarin arm. Started with Apixaban 2.5mg bd but increased to 5mg bd after 25 patients randomised. https://t.co/QqWlorSQy5 #thrombosis #APS https://t.co/JduOWYBpHn